Back to Search
Start Over
Istodax
- Source :
- Formulary. July, 2011, Vol. 46 Issue 7, p248, 1 p.
- Publication Year :
- 2011
-
Abstract
- Romidepsin for injection (Istodax, Celgene) was granted expanded approval to treat peripheral T-cell lymphoma in patients who have received at least 1 prior therapy. Istodax is also approved for treating [...]
- Subjects :
- Celgene Corp. -- Product development
Romidepsin -- Dosage and administration -- Licensing, certification and accreditation
Antineoplastic agents -- Dosage and administration -- Licensing, certification and accreditation
T cell lymphoma -- Drug therapy
Antimitotic agents -- Dosage and administration -- Licensing, certification and accreditation
Pharmaceutical industry -- Product development
Pharmaceuticals and cosmetics industries
Istodax (Medication) -- Licensing, certification and accreditation -- Dosage and administration
Subjects
Details
- Language :
- English
- ISSN :
- 1082801X
- Volume :
- 46
- Issue :
- 7
- Database :
- Gale General OneFile
- Journal :
- Formulary
- Publication Type :
- Periodical
- Accession number :
- edsgcl.264920623